← Back to Clinical Trials
Recruiting NCT07432789

NCT07432789 Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performance of Children With Cerebral Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07432789
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire Dijon
Condition Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2026-03-18
Primary Completion 2028-11-16

Trial Parameters

Condition Cerebral Palsy
Sponsor Centre Hospitalier Universitaire Dijon
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 6 Years
Max Age 18 Years
Start Date 2026-03-18
Completion 2028-11-16
Interventions
Assessment of functional abilitiesChildren's self-questionnairesParent self-assessment questionnaires

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Cerebral palsy is a common neurological disorder that is the leading cause of motor disability in children. It causes significant motor impairments, affecting various aspects such as fine and gross motor skills, as well as locomotion, which has a major impact on the quality of life of affected children. It is therefore essential to characterize these functional impairments in order to guide clinical decisions and maximize the motor function of affected children. Currently, the assessment of motor function is based on physical examinations and functional scales, such as the Gross Motor Function Classification System, which is specifically designed to assess children with CP. However, movement analysis using optoelectronic systems is considered the gold standard for this assessment, even though these systems have notable limitations (expensive installation, time-consuming use, and use only in a clinical environment, making it difficult to assess motor skills in children's everyday lives). In order to establish a comprehensive and personalized functional diagnosis, it is crucial to evaluate other fundamental motor tasks such as running, jumping, object control, and balance tasks. Recently, innovative markerless motion analysis technologies have been developed that allow analysis using smartphones or tablets outside of healthcare facilities. Therefore, developing an application dedicated to motion analysis for children with cerebral palsy that is easy to access and can be used frequently could yield many significant benefits.

Eligibility Criteria

Inclusion Criteria: Common to both groups: * Obtaining free and informed consent from the child and at least one parent * Children of all genders aged 6 to 18 * Children affiliated with or beneficiaries of a social security system For the Cerebral Palsy group: * Medical diagnosis of CP according to the SCPE (Surveillance of Cerebral Palsy in Europe) definition; * Unilateral and bilateral impairment; * Gross Motor Function Classification System (GMFCS) = I to III; * No major cognitive or visual impairments that limit the performance of motor tasks For the control group: \- Children free from any disease Other volunteers included in the protocol (qualitative analysis only (parents and clinicians)): * Parent(s) of children with CP included in this study; * Healthcare professionals and researchers involved in monitoring children with CP and/or evaluating the research application within the framework of this study Exclusion Criteria: Common to both groups: * Participants or parent(s) of par

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology